Focal prostate basal cell layer disruptions and leukocyte infiltration are correlated events: A potential mechanism for basal cell layer disruptions and tumor invasion

Mostofi FK, Price EB Jr. Tumors of the male genital system. Atlas of tumor pathology, 2nd series, Fascicle 8. Washington, DC: Armed Forces Institute of Pathology; 1973. Goldstein, 1999, Cytokeratn 34 beta E-12 immunoreactivity in benign prostate acini. Quantitation, pattern assessment, and electron microscopic study, Am J Clin Pathol, 112, 69, 10.1093/ajcp/112.1.69 Bonkhoff, 1991, Basement membranes in fetal, adult normal, hyperplastic and neoplastic human prostate, Virchows Arch A: Pathol Anat Histopathol, 418, 375, 10.1007/BF01605922 EI-Alfy, 2000, Unique features of the basal cells of human prostate epithelium, Microsc Res Tech, 51, 436, 10.1002/1097-0029(20001201)51:5<436::AID-JEMT6>3.0.CO;2-T Barsky, 1983, Loss of basement membrane components by invasive tumors but not by the benign counterparts, Lab Invest, 49, 140 Goldfarb, 1986, Proteolytic enzymes in cancer invasion and metastasis, Semin Thromb Hemost, 12, 294, 10.1055/s-2007-1003570 Kosir, 1999, Degradation of basement membrane by prostate tumor heparanase, J Surg Res, 81, 42, 10.1006/jsre.1998.5519 Dawson, 2004, Stromal–epithelial interactions influence prostate cancer cell invasion by altering the balance of metallopeptidase expression, Br J Cancer, 90, 1577, 10.1038/sj.bjc.6601717 Udayakumar, 2003, Membrane type-1-matrix metalloproteinase expressed by prostate carcinoma cells cleaves human laminin-5 beta3 chain and induces cell migration, Cancer Res, 63, 2292 Hashimoto, 1998, Expression of matrix metalloproteinase-7 and tissue inhibitor of metalloproteinase-1 in human prostate, J Urol, 160, 1872, 10.1016/S0022-5347(01)62435-2 Coussens, 2002, Matrix metalloproteinase inhibitors and cancer: trial and tribulations, Science, 295, 2387, 10.1126/science.1067100 Matrisian, 2003, Exacellular proteolysis and cancer: meeting summary and future directions, Cancer Res, 63, 6105 Yousefi, 2005, Mammary ducts with and without focal myoepithelial cell layer disruptions show a different frequency of white blood cell infiltration and growth pattern: implications for tumor progression and invasion, Appl Immunohistochem Mol Morphol, 13, 30, 10.1097/00129039-200503000-00006 Man, 2003, Cell clusters overlying focally disrupted mammary myoepithelial cell layers and adjacent cells within the same duct display different immunohistochemical and genetic features: implications for tumor progression and invasion, Breast Cancer Res, 5, R231, 10.1186/bcr653 Man, 2005, cDNA expression profiling reveals elevated gene expression in cell clusters overlying focally disrupted myoepithelial cell layers: implications for breast tumor invasion, Breast Cancer Res Treat, 89, 199, 10.1007/s10549-004-2049-6 Man, 2004, The Significance of focal myoepithelial cell layer disruptions in human breast tumor invasion: a paradigm shift from the “protease-centered” hypothesis, Exp Cell Res, 301, 103, 10.1016/j.yexcr.2004.08.037 Young RH, Srigley JR, Amin MB, et al. Tumors of the prostate gland, semenal vesicles, male urehtra, and penis. Atlas of tumor pathology, 3rd series, Fascicle 28. Washington, DC: Armed Forces Institute of Pathology; 2000. Man, 1996, A simple epitope retrieval method without the use of microwave oven or enzyme digestion, Appl Immunohistochem Mol Morphol, 4, 139 Man, 1995, Persistence of a perinatal cellular phenotype in the ducts of adult glands, J Histochem Cytochem, 43, 1203, 10.1177/43.12.8537636 Man, 2005, Potential roles of T-lymphocytes and natural killer cells in human mammary myoepithelial cell layer disruptions and tumor invasion, Mod Pathol [abstract], 18, 42A, 179 Wang, 2005, Reduction of tumor suppressors and elevation of cytotoxic cells in myoepithelial cell layers of inflammatory breast carcinoma: implication for tumor aggressiveness, Mod Pathol [abstract], 18, 54A, 238 Zhao, 2005, Potential roles of T-lymphocytes and natural killer cells in prostate basal cell layer disruptions and tumor invasion, Mod Pathol [abstract], 18, 175A, 809 McClinton, 1990, An immunohistochemical characterization of the inflammatory cell infiltrate in benign and malignant prostatic disease, Br J Cancer, 61, 400, 10.1038/bjc.1990.87 Steiner, 1994, Phenotype and function of peripheral and prostatic lymphocytes in patients with benign prostatic hyperplasia, J Urol, 151, 480, 10.1016/S0022-5347(17)34998-4 Leiber, 2000, Comparison of the activation status of tumor infiltrating and peripheral lymphocytes of patients with adenocarcinomas and benign hyperplasia of the prostate, Prostate, 45, 1, 10.1002/1097-0045(20000915)45:1<1::AID-PROS1>3.0.CO;2-V Steadman, 1993, Laminin cleavage by activated human neutrophils yields proteolytic fragments with selective migratory properties, J Leukoc Biol, 53, 354, 10.1002/jlb.53.4.354 Heck, 1990, Degradation of basement membrane laminin by human neutrophil elastases and cathepsin G, Am J Pathol, 136, 1267 Bonkhoff, 1996, Differentiation pathways and histogenetic aspects of normal and abnormal prostatic growth: a stem cell model, Prostate, 28, 98, 10.1002/(SICI)1097-0045(199602)28:2<98::AID-PROS4>3.0.CO;2-J Foster, 1997, Stem cells in prostatic epithelia, Int J Exp Pathol, 78, 311, 10.1046/j.1365-2613.1997.380368.x Tobacman, 1997, Filament disassembly and loss of mammary myoepithelial cells after exposure to lambda-carrageenan, Cancer Res, 57, 2823 Bonkhoff, 1998, Analytic molecular pathology of epithelial–stromal interactions in the normal and neoplastic prostate, Anal Quant Cytol Histol, 20, 437 Moinfar, 2000, Concurrent and independent genetic alterations in the stromal and epithelial cells of mammary carcinoma: implications for tumorigenesis, Cancer Res, 60, 2562 Bubendorf, 1996, Ki67 labeling index: an independent predictor of progression in prostate cancer treated by radical prostatectomy, J Pathol, 178, 437, 10.1002/(SICI)1096-9896(199604)178:4<437::AID-PATH484>3.0.CO;2-4 Man, 2001, Contributions of intercalated duct cells to normal parenchyma of submandibular glands of adult rats, Anat Rec, 263, 202, 10.1002/ar.1098